This content is not available in your region

Roche, Spark push back takeover deadline in $4.3 billion deal

Access to the comments Comments
Roche, Spark push back takeover deadline in $4.3 billion deal
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd Wiegmann/File Photo   -   Copyright  Arnd Wiegmann(Reuters)
Text size Aa Aa

ZURICH (Reuters) – Swiss drugmaker Roche <ROG.S> has agreed to extend the takeover deadline in its $4.3 billion (3.43 billion pounds) bid for U.S. gene therapy specialist Spark Therapeutics <ONCE.O>, adding it remains “fully committed” to the transaction and expects it to close this year.

The new deadline for both companies to extend the merger agreement now runs to April 30, 2020, rather than Jan. 31, 2020, Roche said in a U.S. regulatory filing on Monday, saying the change provides “additional time to clear the transaction”.

“Although closing this deal is taking longer than I had hoped, my excitement about our anticipated partnership has only increased,” Roche Chief Executive Severin Schwan wrote in a note to Spark employees that was published by the U.S. Securities and Exchange Commission. “While we still expect this transaction to close in 2019, we want to ensure that we proactively identify and remove any potential future obstacles to achieving this outcome.”

(Reporting by John Miller; Editing by Michael Shields)

euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on for a limited time.